CA-SKYLOOM
6.9.2022 09:01:47 CEST | Business Wire | Press release
Skyloom and Space Compass (a newly formed joint venture between NTT and SKY Perfect JSAT) today announced that the companies signed a term sheet aimed to launch the first geostationary-based (GEO) data relay service over Asia that will leverage Skyloom’s cutting-edge communication and networking systems for the purpose of serving the rapidly growing Earth-Observation (EO) market for real-time, high-capacity, direct-to-cloud data transfer. The companies plan to deploy the first network infrastructure node over Asia in 2024 and anticipate expanding the GEO constellation to provide additional capacity and global coverage by 2026.
Global EO providers are rapidly expanding their constellations, thus creating immense amounts of data, typically in low-earth-orbit (LEO). The Compass-Skyloom system will provide an avenue for immediate, cost-effective transfer of EO data via GEO satellite direct to cloud so that their customers and end-users can leverage perishable information on a real-time basis. The system will rely on optical/laser communications terminals, enabling fibreless optical communications at the speed of business. The partnership combines the space heritage and operations experience of SKY Perfect JSAT, the telecommunications prowess of NTT, and the cutting-edge innovation of Skyloom to unveil both a joint architecture and service for the EO market.
"This new team, leveraging the state-of-the-art telecom technology and infrastructure solutions of Skyloom, will enable us to jointly deliver best-in-class service to our earth observation customers,” said Koichiro Matsufuji, Co-CEO, Space Compass.
“Skyloom is thrilled to be joining forces with Space Compass – which draws on the strengths of two market leaders in space operations and telecommunications. Together we look forward to providing groundbreaking data transport capabilities to the earth observation market, and this is only the beginning of what’s to come,” said Marcos Franceschini, Founder & CEO, Skyloom Global.
"By this partnership, we are excited to be able to provide ultra high-speed and real time data relay in a very economical manner for our customers as a first step toward a larger non-terrestrial network. We believe optical data relay technology is a keystone to innovate networking and computing in orbit between GEO, LEO and ground,” added Shigehiro Hori, Co-CEO, Space Compass.
About Space Compass Corporation
Space Compass is a joint venture company between NTT, Japanese ICT giant, and SKY Perfect JSAT Corporation, Asia’s largest satellite operator. We will launch a Space Integrated Computing Network to aid the realization of a sustainable society. For more information, visit our corporate website, space-compass.com.
About Skyloom Global Corporation
Skyloom is an Oakland, CA-based telecommunications innovator founded with the mission to develop, deploy, and operate one of the fundamental pieces of tomorrow's space communication infrastructure for the provision of data transport services on a planetary scale. They leverage deep heritage in space optical communications to enable real time data transfer so that customers and decisionmakers can leverage perishable information. www.skyloom.co
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005414/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom